Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
esophageal neoplasms/palavik
Link salvestatakse lõikelauale
Leht 1 alates 189 tulemused
[Radiotherapy of esophageal cancer using local hyperthermia and metronidazole (polyradiomodification)].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The results of a dynamic course of radiotherapy alone and in combination with local hyperthermia and metronidazole were studied in 107 patients with esophageal cancer. With relation to the methods applied the patients were divided into 4 groups: the 1st group (40 patients) was given radiotherapy,
Thermometric analysis of intra-cavitary hyperthermia for esophageal cancer.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Thermometric analysis was carried out in 51 patients with esophageal cancer treated with intra-cavitary hyperthermia combined with radio chemotherapy, to test whether temperature index (T20, T50) and T90) could be used as an indicator for tumour control. Hyperthermia was administered by
Preliminary report on the treatment of esophageal cancer by intraluminal microwave hyperthermia and chemotherapy.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Thirty-two cases of esophageal cancer were treated with thermochemotherapy from August 1984 to June 1985. A combination of bleomycin (20 mg per session iv) and cisplatin (0.5-0.9 mg/kg per session as low dose and 1.0-2.0 mg/kg per session as high dose), or of bleomycin, cisplatin (high dose), and
Synergistic antiproliferative effect of delta 12-prostaglandin J2 (delta 12-PGJ2) and hyperthermia on human esophageal cancer cell lines.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
delta 12-PGJ2, one of the cyclopentenone prostaglandins and the ultimate metabolite of prostaglandin D2, has been reported to have potent antiproliferative activity on various tumor cells in vitro and in vivo. In this study, the combined effect of delta 12-PGJ2 and hyperthermia on six established
[Experimental studies on combined chemotherapy with hyperthermia and ethanol for advanced esophageal cancer. I. In vitro effects of combined treatments on 3H-TdR uptake of FM3A cells by microculture method].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The combined effects of hyperthermia, bleomycin and ethanol were investigated using FM3A tumor cells in vitro. Cytotoxicity of the heating was found at temperatures higher than about 41 degrees C, and remarkably increased at 43 degrees C. Cytotoxicity of ethanol was found at concentrations higher
Effectiveness of hyperthermia and radiation treatments for patients with esophageal cancer predicted by the succinate dehydrogenase inhibition test.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
We used in vitro succinate dehydrogenase inhibition test (SDI test) to predict the combined effects of hyperthermia and irradiation on specimens of esophageal cancer obtained at endoscopy. The mean activity of succinate dehydrogenase (SD) after combined treatment of 6 Gy of irradiation and 43.0
Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
To analyse the treatment results of neo-adjuvant chemoradiation combined with regional hyperthermia in patients with resectable esophageal cancer.
METHODS
Between August 2003 and December 2004, 28 patients entered a phase II study combining chemoradiation over a 4.5-week period with five
[Intracavitary microwave hyperthermia combined with external irradiation in the treatment of esophageal cancer].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A randomized trial of intracavitary microwave hyperthermia combined with external irradiation (R + H) versus radiation (R) alone in the treatment of esophageal cancer was performed from Feb. 1986 to Feb. 1988. In the R group, radiation was given by 8 MV X-ray with 2 Gy/fraction, 5 fractions per week
Early report of correlation between the thermal dosage and the treatment effect of hyperthermia in combination with chemoradiotherapy for esophageal cancer patients.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
It is known to be difficult to determine thermal dosage in clinical tumor treatment. The aim of this study is to examine whether the quantitative heating dose reflects the treatment effect in esophageal cancer.
METHODS
Hyperthermo-chemoradiotherapy was performed on 14 patients with
Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
Lymphocyte infiltration (LI) around cancerous lesions is an important immune response. The purpose of this study is to evaluate the prognostic significance of LI after preoperative treatment for esophageal cancer.
METHODS
Preoperative chemoradiotherapy (CR therapy), either bleomycin 30 mg
Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Hyperthermia is considered the fifth pillar of cancer treatment. It induces cancer cell apoptosis, however, its molecular mechanisms remain unclear. In the present study, the role of Survivin in hyperthermia-induced apoptosis in esophageal cancer was investigated. Different temperatures were used to
Additive effects of cepharanthin in CDDP/hyperthermia combination therapy against transplantable human esophageal cancer in nude mice.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
Additive effects of cepharanthin in CDDP/hyperthermia combination therapy were evaluated.
METHODS
Nude mice bearing a transplantable human esophageal cancer (ES0-2), classified histologically as a moderately differentiated squamous cell carcinoma, were treated with cepharanthin (20 mg/kg
[Experimental studies on combined chemotherapy with hyperthermia and ethanol for advanced esophageal cancer. II. Effects of combined treatments on tumor growth in tumor-bearing mice].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The combined effects of local hyperthermia, bleomycin and ethanol were investigated using Lewis lung carcinoma (3LL) in female C57BL/6 mice and FM3A tumors in female C3H/He mice. The combined treatments were performed on days 4 and 7 or on days 4, 7 and 10 after tumor implantation. Hyperthermia at
Local hyperthermia for esophageal cancer in a rabbit tumor model: Magnetic stent hyperthermia versus magnetic fluid hyperthermia.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Magnetic-mediated hyperthermia (MMH) is a promising local thermotherapy approach for cancer treatment. The present study investigated the feasibility and effectiveness of MMH in esophageal cancer using a rabbit tumor model. The therapeutic effect of two hyperthermia approaches, magnetic stent
Magnetic stent hyperthermia for esophageal cancer: an in vitro investigation in the ECA-109 cell line.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Magnetic stent hyperthermia (MSH) is a novel approach for targeted thermotherapy for esophageal cancer, which is based on the mechanism that inductive heat can be generated by the esophageal stent upon exposure under an alternative magnetic field (AMF). A positive effect of MSH on esophageal cancer
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
